Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Relapsing-remitting multiple sclerosis and chronic idiopathic neutropenia: a challenging combination.
Any evident MRI T2-lesion activity should guide change of therapy in multiple sclerosis - Yes.
Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis.
Natalizumab in spinal multiple sclerosis in a daily clinical setting.
Analysis of oxidative stress in zebrafish embryos.
History, applications, and mechanisms of deep brain stimulation.
Increasing age at disability milestones among MS patients in the MSBase Registry.
Vitamin D in MS: A vitamin for 4 seasons.
[Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue.]
Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
Pediatric Multiple Sclerosis.
Motivational interviewing may improve exercise experience for people with multiple sclerosis: A small randomized trial.
Hypovitaminosis D association with disease activity in relapsing remitting multiple sclerosis in Brazil.
Experimental RRMS Therapy to Be Tested in a Phase 2b Clinical Trial
Estimating the proportion of variation in susceptibility to multiple sclerosis captured by common SNPs.
The long-term cost-effectiveness of the use of Functional Electrical Stimulation for the correction of dropped foot due to upper motor neuron lesion.
[Marihuana and cannobinoids as medicaments].
Fat-soluble vitamins as disease modulators in multiple sclerosis.
Biogen Idec and Elan submit applications for first-line use of Tysabri in anti-JCV antibody negative patients with MS
MicroRNAs Regulate Human Brain Endothelial Cell-Barrier Function in Inflammation: Implications for Multiple Sclerosis.
[Oral disease modifying therapy of multiple sclerosis: the current view.]
Aging, widowhood, multiple sclerosis, and a dog.
Atypical forms of optic neuritis.
Cross Cultural Validation of The Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
Increased resistin levels in the serum and cerebrospinal fluid of patients with neuromyelitis optica.

Pages